Market Demand There is a growing healthcare professional interest in non-invasive treatment technologies such as shockwave and EMTT devices, indicating a strong market opportunity for expanding sales to clinics seeking innovative pain management solutions.

Product Launches CuraMedix’s recent introduction of the MAGNETOLITH EMTT device in 2022 demonstrates their commitment to innovative medical equipment, presenting opportunities to promote complementary products and expand their product portfolio.

Industry Position As a leading distributor of STORZ Medical shockwave and EMTT devices within the U.S., CuraMedix is well-positioned to capitalize on the increasing adoption of these technologies among healthcare providers focused on tissue regeneration and musculoskeletal care.

Event Engagement Participation in recent industry conferences such as the Institute for Tissue Regeneration and Repair highlights CuraMedix's active engagement with the medical community, providing avenues for targeted outreach and partnership opportunities.

Financial Opportunity With revenue estimates ranging from one to ten million dollars and a focused product offering, there is potential to identify clinics and practices with comparable or growing budgets that are looking to invest in cutting-edge, non-invasive treatment technologies.